From the publishers of JADPRO

Multiple Myeloma Resource Center

Advertisement
Case Studies
Treatment of Early Relapsed Multiple Myeloma with Iberdomide, Daratumumab and Dexamethasone
Mezigdomide in Triple-Class Relapsed/Refractory Multiple Myeloma
Bispecific Antibody Management in Relapsed Multiple Myeloma
Functional High-Risk Multiple Myeloma
Linvoseltamab in Relapsed/Refractory Multiple Myeloma
Relapsed Multiple Myeloma Treated with Teclistamab
Treatment of Intermediate Risk Smoldering Myeloma
Patient Newly Diagnosed With MM and Ineligible for SCT With Relapse on Anti-CD38 and Lenalidomide-Based Therapy
Treatment of Newly Diagnosed Multiple Myeloma
Single Solitary Plasmacytoma to Active Myeloma
A Heavily Treated Relapsed/Refractory Multiple Myeloma Patient on Talquetamab
First Relapse of Multiple Myeloma Patient
Treatment of Relapsed Multiple Myeloma With Bispecific Antibodies
Early Relapsed Multiple Myeloma With Translocation (11;14)
Advertisement
Case Studies

Treatment of Early Relapsed Multiple Myeloma with Iberdomide, Daratumumab and Dexamethasone

Mezigdomide in Triple-Class Relapsed/Refractory Multiple Myeloma

Treatment of Newly Diagnosed Multiple Myeloma

Advertisement
Quizzes
Test your knowledge of treatment of early relapsed multiple myeloma with iberdomide, daratumumab, and dexamethasone
Test your knowledge of mezigdomide in triple-class relapsed/refractory multiple myeloma
Test your knowledge in a newly diagnosed case presented initially as single solitary plasmacytoma